Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · Real-Time Price · USD
6.36
-0.21 (-3.20%)
Nov 4, 2024, 4:00 PM EST - Market closed
Sensus Healthcare Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Sensus Healthcare stock have an average target of 10, which predicts an increase of 57.23% from the current stock price of 6.36.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 12, 2024.
Analyst Ratings
The average analyst rating for SRTS stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +57.23% | Aug 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $10 | Strong Buy | Maintains | $8 → $10 | +57.23% | May 13, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +57.23% | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +25.79% | Nov 13, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +25.79% | Aug 7, 2023 |
Financial Forecast
Revenue This Year
37.86M
from 24.41M
Increased by 55.14%
Revenue Next Year
46.10M
from 37.86M
Increased by 21.75%
EPS This Year
0.40
from 0.03
Increased by 1,242.15%
EPS Next Year
0.59
from 0.40
Increased by 47.13%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 39.4M | 51.5M | 60.3M |
| Avg | 37.9M | 46.1M | 58.1M |
| Low | 35.7M | 41.1M | 55.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 61.6% | 36.1% | 30.7% |
| Avg | 55.1% | 21.8% | 25.9% |
| Low | 46.1% | 8.6% | 20.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.48 | 0.65 | 0.83 |
| Avg | 0.40 | 0.59 | 0.72 |
| Low | 0.35 | 0.49 | 0.62 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1,519.2% | 62.6% | 40.8% |
| Avg | 1,242.2% | 47.1% | 22.9% |
| Low | 1,082.7% | 22.4% | 4.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.